Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.30
+0.55 (1.91%)
At close: Feb 11, 2026
Market Cap1.07B +21.6%
Revenue (ttm)798.27M +8.3%
Net Income-10.94M
EPS-0.30
Shares Out36.61M
PE Ration/a
Forward PEn/a
Dividend0.25 (0.85%)
Ex-Dividend Daten/a
Volume48,252
Average Volume24,009
Open28.80
Previous Close28.75
Day's Range28.40 - 29.30
52-Week Range18.50 - 35.85
Beta0.91
RSI42.55
Earnings DateMar 26, 2026

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince ... [Read more]

Sector Healthcare
Founded 1962
Employees 210
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements